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Clinical Implications of
Therapeutic Exercise in HIV/AIDS
Christopher M. Bopp, MS
Kenneth D. Phillips, PhD, RN
Laura J. Fulk, MS
Gregory A. Hand, PhD
HIV/AIDS poses serious risks to the health of mil-
lions around the globe. Despite decades of research, no
cure or vaccine has been found to prevent this disease
and the resultant morbidity and mortality. New
antiretroviral drug regimens, such as highly active
antiretroviral therapy (HAART), offer benefits at the
cost of debilitating side effects. Other therapies, such
as steroid and growth hormone administration, are also
effective in treating HIV-related symptoms, but with
serious side effects and increased cost (Basaria,
Wahlstrom, & Dobs, 2001; Schambelan et al., 1996).
Alternative therapies, the most commonly used of
which is therapeutic exercise, are currently being
explored to deal with symptoms and complications of
chronic HIV infection without the unwanted side
effects (Standish et al., 2001).
Therapeutic exercise has been used successfully in
the treatment of diabetes (Albright et al., 2000),
dyslipidemias (Durstine & Haskell, 1994), hyperten-
sion (JNC VI, 1997), cardiovascular disease (Ameri-
can College of Sports Medicine, 1994) and certain
types of cancer (Winningham, MacVicar, Bondoc,
Anderson, & Minton, 1989). The benefits of regular
exercise also extend to the population infected with
HIV. Chronic HIV infection is associated with muscle
wasting, muscle weakness, fatigue, impaired func-
tional work capacity, depression, and decreased qual-
ity of life, which lead to disability and mortality. Exer-
cise can positively affect many aspects of the physical
and mental health of HIV-infected patients.
The effects of prolonged, high-intensity exercise, or
overtraining, have been well documented to increase
the severity of infections and to negatively affect
immune function in humans and increase mortality in
animal models. It is for these reasons that many physi-
cians still instruct their HIV-infected clients to avoid
physical exertion, despite evidence that moderate-
intensity exercise can decrease symptoms of HIV
infection and positively affect immune measures.
Effects of Exercise on
Immunological Measures
In apparently healthy individuals free of HIV infec-
tion, acute, moderate-intensity exercise will cause
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neutrophil proliferation, epinephrine and cortisol
secretion, a temporary decline in lymphocyte levels,
and an elevated number of natural killer cells and
increased cytokine levels (IL-1, TNF-α, IL-6). This
response is blunted in HIV-infected individuals fol-
lowing a single exercise session (Roubenoff et al.,
1999a). Higher intensity exercise sessions decrease
the effectiveness of the immune system, leading to
more opportunistic infections among HIV-free indi-
viduals (Nieman, Johanssen, Lee, & Arabatzis, 1990).
For this reason, high-intensity exercise has been avoided,
and moderate-intensity exercise has been most often
recommended for HIV-infected individuals.
Several immunological variables are of signifi-
cance to HIV-infected patients, including HIV-1 ribo-
nucleic acid viral load and CD4 cell count. Unfortu-
nately, the data available in the literature describing
the relationship of these markers and exercise are
ambiguous. Studies by Smith et al. (2001) and Rigsby,
Dishman, Jackson, Maclean, and Raven (1992) found
that 12 weeks of aerobic exercise and 12 weeks of
combined resistance and aerobic training, respec-
tively, had no effect on viral load or CD4 count.
Roubenoff and colleagues (1999c) found similar
results after 8 weeks of progressive resistance training.
In unpublished data from a recent study, Bopp, Phil-
lips, Fulk, and Hand observed an inverse correlation
between physical activity levels and viral load (r =
–.42, p = .0061). LaPerriere and colleagues (1991)
reported that aerobic conditioning increased CD4 cell
counts. Mustafa and colleagues (1999) found that
HIV-infected individuals self-reporting exercise par-
ticipation had 107.5% higher CD4 counts when com-
pared to HIV-infected individuals who denied exercise
participation. Exercisers also displayed slower disease
progression to AIDS, less symptomology, and
decreased rates of mortality compared to nonexercis-
ers. Finally, MacArthur, Levine, and Birk (1993)
linked lower CD4 cell count levels with noncompli-
ance to prescribed exercise.
Effects of Exercise on
Functional Work Capacity
Maximal oxygen consumption, VO2max (mL/kg/
min), is a common measure of functional work capac-
ity. As physical fitness increases, so too does VO2max
in healthy adults free of HIV infection (Brooks, Fahey,
& White, 1996). A study by Keyser, Peralta, Cade,
Miller, and Anixt (2000) found that adolescents sero-
positive for the HIV virus had average VO2max values
in the upper 20s, placing them in the “well below aver-
age” group compared to age-matched, uninfected con-
trols (American College of Sports Medicine, 2000).
Pothoff, Wassermann, and Ostmann (1994) found that
VO2max values both at the anaerobic threshold and at
maximal exercise were reduced in HIV-infected indi-
viduals compared to a control group of uninfected
individuals.
Therapeutic exercise has been found to increase
functional capacity in HIV-infected individuals. Sig-
nificant increases in functional capacity were seen fol-
lowing 12 weeks (LaPerriere et al., 1991; Smith et al.,
2001) and 24 weeks of aerobic endurance activity
(MacArthur et al., 1993). The effects of this increase in
functional capacity have not been evaluated in an HIV-
infected population, but similar findings in a popula-
tion undergoing cardiac rehabilitation resulted in a
40% improvement in the ability of the participants to
perform activities of daily living (Parker et al., 1996).
If this relationship exists in an HIV-infected popula-
tion, increased functional capacity may decrease HIV-
related disability and allow for longer independent
living.
Effects of Exercise on
Muscular Strength
Adaptations to exercise are dependent on the spe-
cific type of exercise stress applied to the body. Pro-
gressive resistance training causes increases in muscu-
lar strength and muscular hypertrophy. Little has been
published regarding the effects of resistance training
on HIV-infected individuals. A study by Roubenoff
and colleagues (1999b) found that three weekly
strength-training workouts increased one repetition
maximum by 31% to 50% in 8 weeks. More important,
increases in muscular strength were largely main-
tained following 8 additional weeks of self-selected
activity. A study by Rigsby et al. (1992) looked at the
combined effects of both resistance and aerobic train-
ing. Because the response to exercise is specific to the
applied stimulus, the increases in muscular strength
observed by Rigsby and colleagues were not as
significant as those observed by Roubenoff et al. in
individuals exposed exclusively to resistance training.
Effects of Exercise on
Body Composition
One of the side effects of HAART is lipodystrophy,
a condition characterized by fat atrophy from the face,
buttocks, and limbs, as well as fat deposition in the
abdomen (Balt & Nixon, 2001; Carr et al., 1998).
AIDS- and HIV-related wasting, defined as a loss of
greater than 10% of baseline body weight, is another
example of body compositional changes following
HIV infection (MacDougall, 1997). Both aerobic and
resistance exercise can positively affect body compo-
sition in HIV-infected patients. Roubenoff and col-
leagues (1999c) found that resistance training three
times per week for 16 weeks resulted in the loss of 3.3
pounds of body fat, much from the abdomen. This fat
loss occurred without the accelerated peripheral fat
loss seen with testosterone administration. Aerobic
exercise also alters body composition values. Smith
and colleagues (2001) found that after 12 weeks of
endurance training, body mass index (kg/m2), waist
girth, and body weight decreased.
Effects of Exercise on
Psychological Markers
HIV infection is often accompanied by symptoms
of anxiety and depression (Cabaj, 1996). It is well
established that HIV infection can lead to insomnia,
defined as insufficient quantity or quality of sleep
(Nokes & Kendrew, 2001). Insomnia itself may
increase the stress level of an HIV patient, precipitat-
ing more real-life stressors such as unemployment and
decreased quality of life (Darko, Mitler, & White,
1995). In 1987, Membreno et al. first reported elevated
cortisol levels in HIV patients compared to uninfected
patients, presumably from stress.
Several authors have noted a correlation between
HIV disease progression and stress. Leserman et al.
(1997) found a negative correlation between stress lev-
els and lymphocytes in HIV-positive individuals. Sev-
eral studies by Schneiderman (Antoni et al., 2002;
Cruess et al., 2000) indicated that stress management
can delay disease progression and ward off secondary
infections in HIV-seropositive individuals.
Few studies have examined the effects of exercise
on psychological health in an HIV-infected popula-
tion. In 1990, LaPerriere and associates found that aer-
obically trained HIV-infected men were protected
from stress-related impairments in immune function
compared to sedentary controls. A 1997 study by
Stringer, Berezovskaya, O’Brien, Beck, and Casaburi
(1998) found that 6 weeks of aerobic training signifi-
cantly increased quality-of-life scores. Conversely, a
study by Birk, McGrady, MacArthur, and Khuder
(2000) found no significant improvement in mental or
emotional health following 12 weeks of combined
massage and exercise treatment. Muscle wasting,
weakness, fatigue, and disability can contribute to
depression and low quality-of-life scores in HIV-
infected patients. Theoretically, by improving the
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Table 1. Changes in Exercise Parameters With Varying Stages of HIV Infection
Parameter Asymptomatic Early Symptomatic AIDS
Exercise capacity ↓ ↓↓ ↓↓↓
Oxygen consumption ↑ at submaximal workloads • ↑↑ at submaximal workloads More severe dysfunction than
(mL/kg/min) • ↓ at maximal exercise Stage II
• ↓ at ventilatory threshold
Effects of exercise training • ↑↑ CD4 cell count • ↑ CD4 cell count Further research needed
• Delayed symptom onset • ↓ symptom severity
• Increase in muscle size • Delayed onset of AIDS
and strength • Improved quality of life
• ↓ symptom severity • Decreased viral load
• ↓ % body fat • Improved mental health
NOTE: ↑ = increased, ↑↑ = very increased, ↑↑↑ = extremely increased, ↓ = decreased, ↓↓ = very decreased, ↓↓↓ = extremely decreased.
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underlying symptoms that contribute to this depres-
sion, exercise therapy may be able to positively affect




An appropriately trained clinical exercise physiolo-
gist or nurse should monitor all exercise sessions
involving an HIV-infected patient until the patient
demonstrates the ability to tolerate the prescribed
workload. There are several factors that need to be
considered when prescribing exercise for an HIV
patient, including medications, symptoms, functional
capacity, and the stage of disease of the individual
patient. The goals of the exercise prescription should
include the improvement of functional work capacity
and increases in muscular strength.
The number of weekly exercise sessions should be
increased until the patient can tolerate three to five ses-
sions weekly. The duration of each session should
increase until the patient is exercising from 20 to 60
minutes each session. If the patient is debilitated, ses-
sions may be performed discontinuously. For exam-
ple, instead of one 30-minute session, the patient could
perform three 10-minute sessions until able to com-
plete 30 continuous minutes. Exercise should be per-
formed at a moderate intensity: from 11 to 14 on the
Borg Rating of Perceived Exertion Scale, at 50% to
85% of peak heart rate, or at 45% to 85% VO2max.
Heart rate reserve methods such as the Karvonen equa-
tion are not recommended for determining exercise
intensity (LaPerriere, Klimas, Major, & Perry, 1997).
The patient should complete 4 to 6 weeks of aerobic
training before initiating a resistance training pro-
gram. This will improve conditioning and prevent
overtraining, thereby decreasing the chance of
immune complications early in the exercise interven-
tion. Resistance training should focus on large muscle
groups, such as the chest, biceps brachia, quadriceps,
and hamstrings. The intensity should again be moder-
ate. A weight should be selected with which the patient
can comfortably perform 8 to 12 repetitions. Resis-
tance should be increased as 8 to 12 repetitions
become less stressful, or additional sets of 8 to 12
repetitions should be added as the patient can tolerate
the increase workload. When resistance training is
implemented, it is recommended that free weights be
avoided because of the increased risk of injury.
It is recommended that all patients receive medical
clearance from their physicians before beginning exer-
cise programs because of the varied symptomology of
HIV patients. A physician-monitored exercise stress
test is also recommended because several factors may
be present that have the potential to limit exercise tol-
erance. Diarrhea, poor diet, and poor nutrient absorp-
tion place HIV patients at risk for dehydration and
electrolyte abnormalities, both of which can lead to
muscle cramps and cardiac dysrhythmias. Anemia and
muscle wasting can cause increased fatigue and fur-
ther limit exercise capacity. Special care should be
taken if a patient has had previous pneumocystis pneu-
monia because residual lung scarring may decrease
alveolar volume, leading to oxygen desaturation at
moderate exercise intensities, further limiting exercise
capacity.
Clinical Implications
Research supports the use of therapeutic exercise as
an adjunct therapy in the treatment of symptoms of
HIV infection. In patients without acute infections or
severe wasting, exercise therapy should begin as soon
as possible after the diagnosis of HIV infection in an
attempt to delay the onset of symptoms, decrease the
severity of those symptoms already present, and
potentially delay disease progression. Exercise ther-
apy may also decrease the ultimate cost of treating
HIV-infected patients by prolonging the asymptom-
atic period of the disease, thereby decreasing medica-
tion use and health care utilization rates, although fur-
ther research is needed to clarify the effects of exercise
in these areas.
When implementing therapeutic exercise programs
for HIV-infected patients, it is recommended that pro-
grams be individualized on the basis of the functional
capacity and individual symptomology of each client.
Patients present with varying types and intensities of
symptoms so that no one exercise program can ade-
quately deal with the special needs of all HIV-infected
patients. Suggested exercise modalities include
moderate-intensity aerobic activity using large muscle
groups, such as walking, cycling, and rowing. After 5
to 6 weeks of aerobic training, progressive resistance
training can be initiated as described above.
Ainsworth and associates (2000) compiled a com-
pendium of physical activities and their associated
metabolic equivalent (MET) levels. The MET level of
an activity can be determined by dividing its metabolic
cost (in mL/kg/min) of oxygen consumption by 3.5
mL/kg/min, the metabolic cost at rest. With even
asymptomatic HIV-infected individuals having
reduced functional capacities ( VO2max = 28 mL/kg/
min, 8 METs), it is recommended that individuals
exercise at an intensity between 3 and 6 METs. Activ-
ities in this intensity range include bicycling at speeds
less than 10 mph; water aerobics; dancing; routine gar-
dening; walking at 3 mph on a level surface; low-inten-
sity jogging; and low-intensity sports such as badmin-
ton, fencing, and golf (see Table 2) (Ainsworth et al.).
Conclusion
Despite evidence that exercise does not negatively
affect immune measures and can increase CD4 cell
counts, many physicians still caution their HIV-
infected patients against participating in structured
physical activity. Therapeutic exercise has the poten-
tial to increase functional work capacity and muscular
strength and endurance while reversing muscle and fat
wasting and improving several psychological
measures in the HIV-infected population. Exercise
derives these benefits without the high cost and poten-
tially severe side effects of medical and pharmacologi-
cal interventions. Further research is needed to fully
clarify the role of exercise as a complementary treat-
ment for many of the symptoms related to chronic HIV
infection.
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